Evidence map›Paper›PMID 35989789›Full record

ArticleCureus2022

Co-occurrence of CML Blast Crisis and Severe COVID 19 Infection: A Case Report.

Misbahuddin Khaja, Vibha Hayagreev, Asim Haider, Diana Ronderos, Ayesha Siddiqa, Valentina Moirangthem

Abstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Misbahuddin KhajaInternal Medicine/Pulmonary Critical Care, BronxCare Health System, New York, USA.
Vibha HayagreevInternal Medicine, BronxCare Health System, New York, USA.
Asim HaiderInternal Medicine, BronxCare Health System, New York, USA.
Diana RonderosInternal Medicine/Pulmonary Critical Care, BronxCare Health System, New York, USA.
Ayesha SiddiqaInternal Medicine, BronxCare Health System, New York, USA.
Valentina MoirangthemHematology and Oncology, BronxCare Health System, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affecting multiple organ systems. It can cause severe cytokine storms leading to intensive care unit admission requiring mechanical ventilation. However, there have been few studies establishing the outcomes of chronic myeloid leukemia (CML) patients on tyrosine kinase inhibitors who are infected with COVID-19. We present a 69-year-old male with a history of CML on imatinib therapy with COVID-19 who developed acute respiratory distress syndrome needing mechanical ventilatory support, shock requiring vasopressors, and worse outcome secondary to blast crisis.

Indexed as

blast crisischronic myeloid leukemia (cml)corona virus disease 2019imatinib therapyinvasive mechanical ventilation

Identifiers

PMID35989789
PMCPMC9384850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.